Abstract:One receptor, DDR2, both promotes the differentiation of bone-depositing cells and prevents the differentiation of bone-resorbing cells. Reorganizing receptor complexes to rebuild bone The skeleton undergoes continuous turnover mediated by osteoblasts and osteoclasts, which respectively deposit and resorb bone. When this turnover is dysregulated, skeletal diseases such as osteoporosis—a disease characterized by bone loss—can occur. The receptor tyrosine kinase DDR2 (discoidin domain receptor 2) tilts the balance in favor of bone formation. Zhang et al. determined that, in addition to promoting osteoblast differentiation, DDR2 inhibited osteoclast differentiation and bone matrix resorption in culture. In a mouse model of osteoporosis, viral-mediated delivery of DDR2 increased bone density. By forming a complex with the receptors Neuropilin-1 and PlexinA1, DDR2 blocked PlexinA1-mediated stimulation of osteoclastogenesis. Thus, increasing the abundance of DDR2 in both types of bone precursor cells may be therapeutically beneficial for osteoporosis patients. Osteoporosis is a disease characterized by abnormal skeletal fragility due to an imbalance in bone homeostasis. Finding therapeutic targets that promote bone formation is valuable for treating osteoporosis. Discoidin domain receptor 2 (DDR2) is a receptor tyrosine kinase that promotes the differentiation of bone-depositing cells, osteoblasts, and bone formation. We investigated the role of DDR2 in osteoclastogenesis, the formation of cells responsible for bone resorption. We found that, although differentiated osteoclasts had catalytically active DDR2, its abundance was decreased. Overexpression of DDR2 inhibited the expression of osteoclastic markers, osteoclast maturation, and osteoclast-mediated bone resorption in a culture model of bone matrix. Conversely, knocking down Ddr2 through RNA interference accelerated osteoclast differentiation and bone resorption in mice. Further, we identified the co-receptor Neuropilin-1 (Nrp1) as a DDR2-interacting protein. DDR2 facilitated the binding of Nrp1 and the co-receptor PlexinA1 by forming a DDR2-Nrp1-PlexinA1 complex, which blocked PlexinA1-mediated stimulation of osteoclastogenesis. DDR2 prevented PlexinA1 from interacting with the receptor TREM2 and the adaptor DAP12. Moreover, knocking down Nrp1 rescued the expression of osteoclastic markers observed in DDR2-overexpressing cells, whereas ectopic expression of Nrp1 in DDR2-silenced cells inhibited the induction of osteoclastogenesis. Nrp1 enhanced the function of DDR2 in promoting osteoblast differentiation and bone formation in mice. In an ovariectomized mouse model of osteoporosis, adenovirus-mediated delivery of DDR2 to the femur bone alleviated osteopenic phenotypes. Our results revealed that DDR2 functions as an inhibitor of osteoclastogenesis, as well as a promoter of osteoblastogenesis, suggesting that enhancing DDR2 may be therapeutic for patients with osteoporosis.

Ablation of Discoidin Domain Receptor 1 Provokes an Osteopenic Phenotype by Regulating Osteoblast/Osteocyte Autophagy and Apoptosis

Targeting adipocytic discoidin domain receptor 2 impedes fat gain while increasing bone mass

DDR2 (discoidin domain receptor 2) suppresses osteoclastogenesis and is a potential therapeutic target in osteoporosis

Exploring the Cellular and Molecular Mechanism of Discoidin Domain Receptors (DDR1 and DDR2) in Bone Formation, Regeneration, and Its Associated Disease Conditions

NDR2 is Critical for the Osteoclastogenesis by Regulating ULK1-mediated Mitophagy.

An Essential Role of Discoidin Domain Receptor 2 (DDR2) in Osteoblast Differentiation and Chondrocyte Maturation Via Modulation of Runx2 Activation

Discoidin domain receptor 1-deletion ameliorates fibrosis and promotes adipose tissue beiging, brown fat activity, and increased metabolic rate in a mouse model of cardiometabolic disease

DEC1 deficiency results in accelerated osteopenia through enhanced DKK1 activity and attenuated PI3KCA/Akt/GSK3β signaling

RhoA Promotes Osteoclastogenesis and Regulates Bone Remodeling Through Mtor-Nfatc1 Signaling.

Discoidin Receptor 2 Controls Bone Formation and Marrow Adipogenesis

Cbfβ deletion in mice recapitulates cleidocranial dysplasia and reveals multiple functions of Cbfβ required for skeletal development

DKK-1 and Its Influences on Bone Destruction: A Comparative Study in Collagen-Induced Arthritis Mice and Rheumatoid Arthritis Patients.

DDB1 Promotes the Proliferation and Hypertrophy of Chondrocytes During Mouse Skeleton Development.

Dicer1 ablation in osterix positive bone forming cells affects cortical bone homeostasis

Age-Related Decrease in Pellino-1 Expression Contributes to Osteoclast-Mediated Bone Loss

Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction.

Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption

Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization.

A discoidin domain receptor 1 knock-out mouse as a novel model for osteoarthritis of the temporomandibular joint

Low-density lipoprotein receptor deficiency reduced bone mass in mice via the c-fos/NFATc1 pathway

The Effect of Suppressing Discoidin Domain Receptor Expression on Keloid Formation and Proliferation .